Diabetes

Jesse McCullough, PharmD, director of field clinical services for Rite Aid, discusses the implications of a pharmacist-led intervention to boost medication adherence.

Community pharmacists dramatically boost medication adherence among patients with chronic conditions.

In a recent study, patients with diabetes who were referred to a pharmacist-led clinic by their primary care providers saw their mean HbA1C levels fall by 2.4%.

American adults are eating too little fish to meet current recommendations for fish-derived omega-3 fatty acids.

Moderate intake of long chain omega-3 polyunsaturated fatty acids as a lipid-lowering strategy appears to have no effects on glucose regulation or insulin resistance.

Researchers in Taiwan have found an increased risk for head and neck cancers among patients with diabetes mellitus.

Researchers in Taiwan have found an increase in the risk for head and neck cancers among patients with diabetes mellitus (DM) equivalent to approximately 2.6 additional cases per 10,000 person-years in patients with DM versus patients without DM.

Diabetes control worsened for patients with diabetes who received or were receiving androgen deprivation therapy for prostate cancer.

Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses how all pharmacies can manage diabetes patients.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the training pharmacists should pursue if they are interested in playing a role in patient-centered diabetes care.

Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.

Pharmacists can make a difference through screening, counseling, and treatment.

An analysis of 2 randomized trials of statin therapy for patients enrolled after an acute coronary syndrome finds that high-dose statins do not increase the risk of kidney injury.